Atlas Trials

Safety and Efficacy of Sonocloud Device Combined With Nivolumab in Brain Metastases From Patients With Melanoma

Clinical trial NCT04021420 · UNKNOWN

Trial details

NCT number
NCT04021420
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
MelanomaMetastatic Melanoma
Start date
2019-10-24
Primary completion
2022-01-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.